Patents Assigned to BROAD INSTITUTE
  • BIOMARKERS ASSOCIATED WITH CDK INHIBITORS
    Publication number: 20150322528
    Abstract: The invention provides methods of monitoring differential gene expression of biomarkers to determine patient sensitivity to Cyclin Dependent kinase inhibitors (CDKi), methods of determining the sensitivity of a cell to a CDKi, methods of treating a patient with a CDKi and methods of screening for candidate CDKi.
    Type: Application
    Filed: June 26, 2013
    Publication date: November 12, 2015
    Applicants: NOVARTIS AG, BROAD INSTITUTE, DANA-FARBER CANCER INSTITUTE INC.
    Inventors: Giordano Caponigro, Scott Delach, Levi Garraway, Zainab Jagani, Sunkyu Kim, Gregory Kryukov